Prof. Jonathan Rabinowitz, of Bar-Ilan University has been appointed to the Advisory Group on Promoting Good Analysis Practice in relation to European Medicines Agency (EMA) Clinical Trial Data and Transparency. He will also co-chair of the Program Committee for the Biennial Schizophrenia International Research Society Conference to take place in Florence, Italy.
http://www1.biu.ac.il/indexE.php?id=33&pt=20&pid=117&level=2&cPath=33&type=1&news=1815